Skip to content

A randomised open labelled double arm clinical study of uttarvasti with varunadi tailam and dhanwantri tailam in vatasthila w,s.r. to benign prostate hyperplasia

A randomised open labelled double arm clinical study of uttarvasti with varunadi tailam and dhanwantri tailam in vatasthila w,s.r. to benign prostate hyperplasia

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048678
Enrollment
40
Registered
2023-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms

Interventions

None listed

Sponsors

Dr Rohit kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient diagnosed with post voidable urine volume less than 100ml . 2. Patient willing for uttarvasti procedure. 3. Having symptoms of BPH. 4. Patient diagnosed as BPH by both clinical sign symptoms and USG were included.

Exclusion criteria

Exclusion criteria: 1. Urethral stricture 2. Raised PSA. 3. K/C/O Malignancy of Urogenital System. 4. K/C/O Congenital deformities of Urogenital Tract . 5. K/C/O Renal failure , Uretric calculi , renal calculi , chronic UTI. 6. Uncontrol Diabetes mellitus 7. Hypertension 8. Cardiac problem 9. Liver disease .

Design outcomes

Primary

MeasureTime frame
change in the scoring of incomplete emptying , frequency , Intermittency , urgency , weak stream , Straining , Nocturia symptoms reduce after giving Uttarvasti 2. Complete reduction of the BPH Size .Timepoint: 21 days

Secondary

MeasureTime frame
1. Any general improvement of in other aspects of health. 2. lack of RecurrenceTimepoint: 2 month

Countries

India

Contacts

Public ContactDr T Udayakiran

jayendra saraswathi ayurveda college and hospital

dr_tenneti@yahoo.co.in9849666054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026